Hotline:
+ 49 (0) 2204 2918806
Life Sciences
Biological science comprises the whole spectrum of medical research. It includes pharmacy, health care, medical devices and diagnostics. Due to its many direct and indirect impacts, an increased focus has shifted to biotechnology during the last couple of years. Many biotech companies have developed into pharmaceutical and bio-pharmaceutical giants. The biological branch plays an important role for the majority of our society and therefore proved to be an area of particular commercial success. This also explains the strong interest in information potentially providing a strategic market advantage. This category offers diverse information on topics such as digital radiography, laboratory diagnostics, haematology, oncology etc.
Subscribe to RSS Feed

Market studies for category Life Sciences

Items 1 to 10 of 1543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 155
  1. Net price*
    Year
  2. $2,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Israel In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

    GlobalData
    260 pages
    Introduction GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Israel In Vitro Diagnostics market. The report provides value (USD mill
    Englisch | Report | SKU: 329276
  3. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Pharminox Limited – Product Pipeline Review – 2012

    Global Markets Direct
    28 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Pharminox Limited - Product Pipeline Review - 2012” provides data on the Pharminox Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects
    Englisch | Product Pipeline Review | SKU: 317804
  4. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Femta Pharmaceuticals, Inc. – Product Pipeline Review – 2012

    Global Markets Direct
    24 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Femta Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Femta Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued
    Englisch | Report | SKU: 318444
  5. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Thromboembolism – Pipeline Review, H2 2012

    Global Markets Direct
    129 pages
    Introduction Global Markets Direct’s, 'Thromboembolism - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Thromboembolism, complete with latest updates, and special features on late-stage and discontinued projects. It also revi
    Englisch | Report | SKU: 317514
  6. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Ardelyx, Inc. – Product Pipeline Review – 2012

    Global Markets Direct
    25 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Ardelyx, Inc. - Product Pipeline Review - 2012” provides data on the Ardelyx, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This r
    Englisch | Report | SKU: 318156
  7. $2,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Rheumatoid Arthritis - Current and Future Players

    GlobalData
    49 pages
    Introduction GlobalData has released its pharma report, “PharmaPoint: Rheumatoid Arthritis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Rheumatoid Arthritis Market. The report identifies and analyses the key companies shaping and dr
    Englisch | Report | SKU: 330437
  8. $2,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Chile Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2018

    Global Markets Direct
    149 pages
    Introduction Global Markets Direct’s new report, ”Chile Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2018”, provides key market data on the Chile Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven mark
    Englisch | Report | SKU: 317868
  9. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Verva Pharmaceuticals Limited – Product Pipeline Review – 2012

    Global Markets Direct
    31 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Verva Pharmaceuticals Limited - Product Pipeline Review - 2012” provides data on the Verva Pharmaceuticals Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontin
    Englisch | Report | SKU: 318508
  10. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Myeloid Metaplasia – Pipeline Review, H2 2012

    Global Markets Direct
    38 pages
    Introduction Global Markets Direct’s, 'Myeloid Metaplasia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myeloid Metaplasia, complete with latest updates, and special features on late-stage and discontinued projects. It als
    Englisch | Pipeline Review | SKU: 317580
  11. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Japanese Encephalitis – Pipeline Review, H2 2012

    Global Markets Direct
    57 pages
    Introduction Global Markets Direct’s, 'Japanese Encephalitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Japanese Encephalitis, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Report | SKU: 318220

Items 1 to 10 of 1543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 155